Mechanism and research progress of MAPK signaling pathway in myocardial fibrosis
Frontiers in Cardiovascular Medicine · 21.11.2025 · 12
DOI: 10.3389/fcvm.2025.1667568 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.11.2025. Verfasst von Jinqiao Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial fibrosis (MF) is a hallmark pathological outcome of many cardiovascular diseases and a key component of cardiac remodeling. The p38 MAPK, JNK, and ERK signaling pathways are central to this process. This review summarizes the roles and interactions of these factors in MF and identifies relevant drug and non-pharmacological therapies targeting these pathways.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
- Department of Cardiovascular Diseases 1, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Zitieren
APA
Wu, J., Chen, M., Peng, Z., Sun, Y., & Jin, J. (2025). Mechanism and research progress of MAPK signaling pathway in myocardial fibrosis. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1667568
Vancouver
Wu J, Chen M, Peng Z, Sun Y, Jin J. Mechanism and research progress of MAPK signaling pathway in myocardial fibrosis. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1667568
BibTeX
@article{Wu2025,
author = {Wu, Jinqiao and Chen, Min and Peng, Ze and Sun, Yao and Jin, Juan},
title = {Mechanism and research progress of MAPK signaling pathway in myocardial fibrosis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1667568}
}
EUVIMED